BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC
41 results:

  • 1. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer.
    Tan Z; Deme P; Boyapati K; Claes BSR; Duivenvoorden AAM; Heeren RMA; Tressler CM; Haughey NJ; Glunde K
    Breast Cancer Res; 2023 Nov; 25(1):148. PubMed ID: 38017485
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer.
    Li X; Zhang Y; Zhang T; Zhao L; Lin CG; Hu H; Zheng H
    Cancer Gene Ther; 2024 Jan; 31(1):69-81. PubMed ID: 37935981
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lipidome of mammographic breast density in premenopausal women.
    Getz KR; Jeon MS; Luo C; Luo J; Toriola AT
    Breast Cancer Res; 2023 Oct; 25(1):121. PubMed ID: 37814330
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lysophosphatidylcholine-DHA Specifically Induces Cytotoxic Effects of the MDA-MB-231 Human breast cancer Cell Line
    Mohamad Ali D; Hogeveen K; Orhant RM; Le Gal de Kerangal T; Ergan F; Ulmann L; Pencreac'h G
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432249
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparing the accuracy of shear wave elastography and strain elastography in the diagnosis of breast tumors: A systematic review and meta-analysis.
    Wu H; Wang C; An Q; Qu X; Wu X; Yan Y
    Medicine (Baltimore); 2022 Nov; 101(44):e31526. PubMed ID: 36343055
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy.
    Li L; Zhan Q; Yi K; Chen N; Li X; Yang S; Hou X; Zhao J; Yuan X; Kang C
    J Mater Chem B; 2022 Mar; 10(11):1833-1842. PubMed ID: 35212350
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole breast Irradiation.
    Sayan M; Yehia ZA; Jan I; Gupta A; Vergalasova I; Reviello M; Kumar S; Haffty B; Ohri N
    Anticancer Res; 2022 Jan; 42(1):53-57. PubMed ID: 34969708
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls.
    Wolrab D; Jirásko R; Peterka O; Idkowiak J; Chocholoušková M; Vaňková Z; Hořejší K; Brabcová I; Vrána D; Študentová H; Melichar B; Holčapek M
    Sci Rep; 2021 Oct; 11(1):20322. PubMed ID: 34645896
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Umbilical Cord Management at Term and Late Preterm Birth: A Meta-analysis.
    Gomersall J; Berber S; Middleton P; McDonald SJ; Niermeyer S; El-Naggar W; Davis PG; Schmölzer GM; Ovelman C; Soll RF;
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632933
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Shedding of cancer susceptibility candidate 4 by the convertases pc7/furin unravels a novel secretory protein implicated in cancer progression.
    Duval S; Abu-Thuraia A; Elkholi IE; Chen R; Seebun D; Mayne J; Côté JF; Figeys D; Seidah NG
    Cell Death Dis; 2020 Aug; 11(8):665. PubMed ID: 32820145
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Structure guided design of potent indole-based ATX inhibitors bearing hydrazone moiety with tumor suppression effects.
    Lei H; Li C; Yang Y; Jia F; Guo M; Zhu M; Jiang N; Zhai X
    Eur J Med Chem; 2020 Sep; 201():112456. PubMed ID: 32535330
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lipid biosignature of breast cancer tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Silva CL; Perestrelo R; Sousa-Ferreira I; Capelinha F; Câmara JS; Petković M
    Breast Cancer Res Treat; 2020 Jul; 182(1):9-19. PubMed ID: 32415496
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of breast cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential cancer Biomarkers.
    Zhang Q; Xu H; Liu R; Gao P; Yang X; Jin W; Zhang Y; Bi K; Li Q
    Anal Chem; 2019 Mar; 91(5):3389-3396. PubMed ID: 30689358
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dosimetric effects of the kV based image-guided radiation therapy of prone breast external beam radiation: Towards the optimized imaging frequency.
    Xu H; Lee SW; Guerrero M; Yi BY; Chen S; Becker SJ; Chung H; Cheston SB
    J Appl Clin Med Phys; 2019 Jan; 20(1):212-219. PubMed ID: 30550644
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
    Panet F; Couture F; Kwiatkowska A; Desjardins R; Guérin B; Day R
    Eur J Cell Biol; 2017 Aug; 96(5):469-475. PubMed ID: 28347547
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combined Laser Photocoagulation and anti-VEGF Injection Treatment in Radiation Retinopathy.
    Hurtikova K; Gerding H
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):515-519. PubMed ID: 28282695
    [No Abstract]    [Full Text] [Related]  

  • 19. Non-invasive optical spectroscopic monitoring of breast development during puberty.
    Lilge L; Terry MB; Walter J; Pinnaduwage D; Glendon G; Hanna D; Tammemagi ML; Bradbury A; Buys S; Daly M; John EM; Knight JA; Andrulis IL
    Breast Cancer Res; 2017 Feb; 19(1):12. PubMed ID: 28166807
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.